Krishna Yeshwant's Net Worth
$985 Thousand
Who is Krishna Yeshwant?
Krishna Yeshwant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verve Therapeutics, Inc., EQRx, Inc., and Foundation Medicine, Inc..
SEC CIK
Krishna Yeshwant's CIK is 0001585001
Past Insider Trading and Trends
2017 was Krishna Yeshwant's most active year for acquiring shares with 2 total transactions. Krishna Yeshwant's most active month to acquire stocks was the month of May. 2017 was Krishna Yeshwant's most active year for disposing of shares, totalling 4 transactions. Krishna Yeshwant's most active month to dispose stocks was the month of July. 2017 saw Krishna Yeshwant paying a total of $555,780.15 for 19,171 shares, this is the most they've acquired in one year. In 2018 Krishna Yeshwant cashed out on 5,786 shares for a total of $792,682.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
∞
| 1.8M |
$10.00 | $18,000,000.00 | 1.8M |
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| -0.93% | -97.17K |
$31.14 | -$1,512,805.94 | 10.37M |
Scheduled
|
Nov 4
| ||
Form 4
| -1.47% | -156.44K |
$33.95 | -$2,655,329.77 | 10.47M |
Scheduled
|
Nov 2 - Nov 3
| ||
Form 4
| -1.59% | -171.32K |
$37.95 | -$3,250,495.91 | 10.62M |
Scheduled
|
Oct 31 - Nov 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 10.79M |
—
|
—
| 10.79M |
Jun 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EQRx, Inc. (EQRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
InvestorKrishna Yeshwant used to own units in Common Stock but no longer holds any shares there.acquired a total of 37,243 shares in Foundation Medicine, Inc. at a cost of $989,718.21, Krishna also disposed a total of 37,243 shares of Foundation Medicine, Inc. equalling to $1,974,766.95.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.79K |
$137.00 | -$792,682.00 |
0
|
Jul 31
| |||
Form 4
| -45.34% | -4.80K |
$40.01 | -$192,048.00 | 5.79K |
Aug 8
| |||
Form 4
| -55.63% | -13.27K |
$30.68 | -$665,986.10 | 10.59K |
Aug 4
| |||
Form 4
| +32.02% | 5.79K |
$40.05 | $231,729.30 | 23.86K |
Jun 20
| |||
Form 4
| +201.35% | 12.07K |
$19.93 | $240,654.75 | 18.07K |
Jun 16
| |||
Form 4
|
∞
| 6K |
$32.23 | $193,283.31 | 6K |
Jun 18
| |||
Form 4
| -100.00% | -183.86K |
$32.98 | -$6,062,972.89 |
0
|
Jun 11 - Jun 15
| |||
Form 4
| -4.47% | -8.60K |
$38.57 | -$331,702.00 | 183.86K |
May 14
| |||
Form 4/A
| -83.19% | -952.19K |
$50.00 | -$47,609,600.00 | 192.46K |
Apr 7
| |||
Form 4
| -80.70% | -923.74K |
$50.00 | -$46,186,750.00 | 220.92K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -53.18% | -1.30M |
$22.40 | -$29,120,000.00 | 1.14M |
Jun 13
| |||
Form 4
|
∞
| 2.44M |
—
|
—
| 2.44M |
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||